Search results for "Imidazolines"

showing 3 items of 3 documents

1H, 13C and 15N NMR spectral characterization of twenty-seven 1,2-diaryl-(4E)-arylidene-2-imidazolin-5-ones.

2006

1H, 13C and 15N NMR chemical shifts and couplings nJ(H,C) in DMSO-d6 at 30 °C have been determined for 1,2-diaryl-(4E)-arylidene-2-imidazolin-5-one derivatives 1–27. Their chemical shift assignments are based on PFG DQF 1H,1H COSY, PFG 1H,13C HMQC as well as PFG 1H,13C and 1H,15N HMBC experiments. For compounds 1–10 including aryl fluorine substituent(s) also the couplings nJ(F,C) (n = 1 − 4) are reported. Copyright © 2006 John Wiley & Sons, Ltd.

Carbon IsotopesMagnetic Resonance SpectroscopyMolecular StructureNitrogen IsotopesStereochemistryArylChemical shiftSubstituentchemistry.chemical_elementGeneral ChemistryCarbon-13 NMRchemistry.chemical_compoundchemistryProton NMRFluorineGeneral Materials ScienceImidazolinesHydrogenMagnetic resonance in chemistry : MRC
researchProduct

Molecular modeling approaches in the discovery of new drugs for anti-cancer therapy: the investigation of p53-MDM2 interaction and its inhibition by …

2010

The mdm2 oncogene product, MDM2, is an ubiquitin protein ligase that inhibits the transcriptional activity of the tumor suppressor p53 and promotes its degradation. About 50% of all human cancers present mutations or deletions in the TP53 gene. In the remaining half of all human neoplasias that express the wild-type protein, aberrations of p53 regula- tors, such as MDM2, account for p53 inhibition. For this reason, designing small-molecule inhibitors of the p53-MDM2 protein-protein interaction is a promising strategy for the treatment of cancers retaining wild-type p53. The development of inhibitors has been challenging. Although many small-molecule MDM2 inhibitors have shown potent in vitr…

IndolesTumor suppressor geneAntineoplastic AgentsMolecular Dynamics SimulationBioinformaticsBiochemistryGene productNeoplasmsDrug DiscoverymedicineHumansImidazolinesMolecular Modeling New Drugs for Anti-Cancer Therapy p53-MDM2 InteractionPharmacologyBenzodiazepinonesbiologyOncogeneOrganic ChemistryCancerProto-Oncogene Proteins c-mdm2medicine.diseaseSettore CHIM/08 - Chimica FarmaceuticaSmall moleculeUbiquitin ligaseOxindolesProtein Structure TertiaryDrug Designbiology.proteinCancer researchMolecular MedicineMdm2PharmacophoreTumor Suppressor Protein p53Current medicinal chemistry
researchProduct

The lineshape of the electronic spectrum of the green fluorescent protein chromophore, part I: gas phase.

2014

The vibronic spectra of the green fluorescent protein chromophore analogues p-hydroxybenzylidene-2,3-dimethylimidazolinone (HBDI) and 3,5-tert-butyl-HBDI (35Bu) are similar in the vacuum, but very different in water or ethanol. To understand this difference, we have computed the vibrationally resolved solution spectra of these chromophores, using the polarizable continuum model (PCM) to account for solvent effects on the (harmonic) potential energy surfaces (PES). In agreement with experiment, we found that the vibrational progression increases with the polarity of the solvent, but we could neither reproduce the broadening, nor the large difference between the absorption spectra of HBDI and…

Vibrational spectroscopyComputational chemistrygenetic structuresAbsorption spectroscopySpectrophotometry InfraredPopulationGreen Fluorescent ProteinsAnalytical chemistryElectronsPolarizable continuum modelMolecular physicsAbsorptionMolecular dynamicsBenzyl CompoundsVibronic spectroscopyGreen fluorescent proteinPhysical and Theoretical ChemistryeducationImidazolinesta116education.field_of_studyChemistryTemperatureChromophoreChromophoresPotential energyAtomic and Molecular Physics and OpticsQuantum TheoryThermodynamicsGasesSolvent effectsChemphyschem : a European journal of chemical physics and physical chemistry
researchProduct